Roy D. Baynes Natera, Inc. (NTRA) insider trading activity

Roy D. Baynes is of Natera, Inc.. Currently has a direct ownership of 18,359 shares of NTRA, which is worth approximately $3.75 Million. The most recent transaction as insider was on Nov 20, 2025, when has been sold 7,668 shares (Common Stock) at a price of $222.73 per share, resulting in proceeds of $1,707,893. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.4K

0.51% 3M change

16.14% 12M change

Total Value Held $3.75 Million

Roy D. Baynes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2025	SELL Open market or private sale	$1,707,893 $222.73 p/Share	7,668 Reduced 29.46%	18,359 Common Stock
Nov 20 2025	BUY Exercise of conversion of derivative security	$314,848 $41.06 p/Share	7,668 Added 22.76%	26,027 Common Stock
Nov 19 2025	SELL Open market or private sale	$1,097,955 $214.78 p/Share	5,112 Reduced 21.78%	18,359 Common Stock
Nov 19 2025	BUY Exercise of conversion of derivative security	$209,234 $40.93 p/Share	5,112 Added 17.88%	23,471 Common Stock
Oct 31 2025	BUY Grant, award, or other acquisition	-	93 Added 0.5%	18,359 Common Stock
Jul 25 2025	BUY Grant, award, or other acquisition	-	108 Added 0.59%	18,266 Common Stock
Jun 27 2025	BUY Grant, award, or other acquisition	-	2,143 Added 10.56%	18,158 Common Stock

Apr 25 2025	BUY Grant, award, or other acquisition	-	116 Added 0.72%	16,015 Common Stock
Jan 31 2025	BUY Grant, award, or other acquisition	-	92 Added 0.58%	15,899 Common Stock
Nov 15 2024	SELL Open market or private sale	$5,471,320 $146.96 p/Share	37,230 Reduced 70.2%	15,807 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	$879,744 $23.63 p/Share	37,230 Added 41.24%	53,037 Common Stock
Oct 25 2024	BUY Grant, award, or other acquisition	-	124 Added 0.78%	15,807 Common Stock
Jul 26 2024	BUY Grant, award, or other acquisition	-	143 Added 0.9%	15,683 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	-	2,964 Added 16.02%	15,540 Common Stock
Apr 26 2024	BUY Grant, award, or other acquisition	-	169 Added 1.33%	12,576 Common Stock
Jan 26 2024	BUY Grant, award, or other acquisition	$13,714 $63.79 p/Share	215 Added 1.7%	12,407 Common Stock
Oct 27 2023	BUY Grant, award, or other acquisition	$13,717 $42.6 p/Share	322 Added 2.57%	12,192 Common Stock
Jul 28 2023	BUY Grant, award, or other acquisition	$12,798 $48.48 p/Share	264 Added 2.18%	11,870 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	-	2,750 Added 19.16%	11,606 Common Stock
May 25 2023	BUY Exercise of conversion of derivative security	-	3,534 Added 28.52%	8,856 Common Stock
Apr 14 2023	BUY Grant, award, or other acquisition	$12,478 $54.73 p/Share	228 Added 4.11%	5,322 Common Stock
Jan 13 2023	BUY Grant, award, or other acquisition	$12,483 $40.01 p/Share	312 Added 5.77%	5,094 Common Stock
Oct 14 2022	BUY Grant, award, or other acquisition	$12,490 $45.42 p/Share	275 Added 5.44%	4,782 Common Stock
May 25 2022	BUY Exercise of conversion of derivative security	-	1,307 Added 23.89%	4,163 Common Stock
May 28 2021	BUY Exercise of conversion of derivative security	-	2,856 Added 50.0%	2,856 Common Stock

Also insider at

TVTX

Travere Therapeutics, Inc. Healthcare

ATRA

Atara Biotherapeutics, Inc. Healthcare

NRIX

Nurix Therapeutics, Inc. Healthcare

Director

AARD

Aardvark Therapeutics, Inc.

RDB

Roy D. Baynes

Austin, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTRA shares.

Notify only if

Value

Insider Trading

Get notified when an Natera, Inc. insider buys or sells NTRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Natera, Inc.

Track Activities on NTRA

Account